Chemmedchem

Chemmedchem

化学化工

  • 4区 中科院分区
  • Q2 JCR分区

期刊简介

《Chemmedchem》是由John Wiley and Sons Ltd出版社于2006年创办的英文国际期刊(ISSN: 1860-7179,E-ISSN: 1860-7187),该期刊长期致力于药物化学领域的创新研究,主要研究方向为医学-药学。作为SCIE收录期刊(JCR分区 Q2,中科院 4区),本刊采用OA未开放获取模式(OA占比0.0959...%),以发表药物化学领域等方向的原创性研究为核心(研究类文章占比86.14%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在202篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Chemmedchem审稿周期约为 约1.0个月 。该刊近年未被列入国际预警名单,年发文量约202篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 202 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
CHEMISTRY, MEDICINAL 药物化学 PHARMACOLOGY & PHARMACY 药学
4区 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
CHEMISTRY, MEDICINAL 药物化学 PHARMACOLOGY & PHARMACY 药学
4区 4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q2 31 / 72

57.6%

学科:PHARMACOLOGY & PHARMACY SCIE Q2 94 / 354

73.6%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q2 30 / 72

59.03%

学科:PHARMACOLOGY & PHARMACY SCIE Q2 112 / 354

68.5%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:6.7 SJR:0.761 SNIP:0.75
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:General Pharmacology, Toxicology and Pharmaceutics Q1 9 / 80

89%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Organic Chemistry Q2 56 / 211

73%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology Q2 98 / 313

68%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Drug Discovery Q2 53 / 157

66%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Biochemistry Q2 155 / 438

64%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Molecular Medicine Q2 70 / 178

60%

期刊发文

  • Emerging and Versatile Platforms of Metal-Ion-Doped Carbon Dots for Biosensing, Bioimaging, and Disease Therapy

    Author: Qian, Sihua; Li, Lin; Wu, Kerong; Wang, Yuhui; Wei, Gang; Zheng, Jianping

    Journal: CHEMMEDCHEM. 2023; Vol. 18, Issue 1, pp. -. DOI: 10.1002/cmdc.202200479

  • Strategies toward Metal-Free Carbon Monoxide Prodrugs: An Update

    Author: Min, Qingqiang; Ji, Xingyue

    Journal: CHEMMEDCHEM. 2023; Vol. 18, Issue 1, pp. -. DOI: 10.1002/cmdc.202200500

  • Surface Modification of Bacteria to Optimize Immunomodulation for Advanced Immunotherapy

    Author: Xue, Kaikai; Wang, Lu; Liu, Jinyao

    Journal: CHEMMEDCHEM. 2023; Vol. 18, Issue 3, pp. -. DOI: 10.1002/cmdc.202200574

  • Praziquantel-50 Years of Research

    Author: Waechtler, Andreas; Cezanne, Bertram; Maillard, David; Sun, Rui; Wang, Shaofang; Wang, Jihua; Harder, Achim

    Journal: CHEMMEDCHEM. 2023; Vol. , Issue , pp. -. DOI: 10.1002/cmdc.202300154

  • Design, Synthesis and Biological Evaluation of 7-Substituted-1,3-diaminopyrrol[3,2-f]quinazolines as Potential Antibacterial Agents

    Author: Yuan, Duo; Liu, Shangde; Li, Shanshan; Liu, Rongrong; Zhu, Xiong

    Journal: CHEMMEDCHEM. 2023; Vol. , Issue , pp. -. DOI: 10.1002/cmdc.202300078

  • Design, Synthesis, and Biological Evaluation of Histone Deacetylase Inhibitors Derived from Erianin and Its Derivatives

    Author: Yang, Yawen; Liu, Qingqing; Wang, Xinyi; Gou, Shaohua

    Journal: CHEMMEDCHEM. 2023; Vol. , Issue , pp. -. DOI: 10.1002/cmdc.202300108

  • Switching the Mode of Cell Death between Apoptosis and Autophagy by Histone Deacetylase 6 Inhibition Levels

    Author: Zhou, An-Min; Wang, Meng-Meng; Su, Yan; Yu, Zheng-Hong; Liu, Hong-Ke; Su, Zhi

    Journal: CHEMMEDCHEM. 2023; Vol. 18, Issue 5, pp. -. DOI: 10.1002/cmdc.202200614

  • NaClO-Mediated Cross Installation of Indoles and Azoles Benefits Anticancer Hit Discovery

    Author: Yu, Changjun; E., Ruiyao; Zhang, Xiao-Wei; Hu, Wen-Qian; Bao, Guangjun; Li, Yiping; Liu, Yuyang; He, Zeyuan; Li, Jingyue; Ma, Wen; Mou, Ling-Yun; Wang, Rui; Sun, Wangsheng

    Journal: CHEMMEDCHEM. 2023; Vol. 18, Issue 5, pp. -. DOI: 10.1002/cmdc.202200651